ArticleDiagnostics (Basel, Switzerland)2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.
Bertha Eisses, Lindsay Angus, Evelien J M Kuip, C Willemien Menke-van der Houven van Oordt, Bert van der Vegt, Andor W J M Glaudemans, Adrienne H Brouwers, Daniela E Oprea-Lager, Wim J G Oyen, Jasper Emmering and 8 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Bertha EissesDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0002-9288-0353 Lindsay AngusDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.ORCID 0000-0002-7928-1102 Evelien J M KuipDepartment of Medical Oncology, Radboud Medical Center, 6500 HK Nijmegen, The Netherlands.
C Willemien Menke-van der Houven van OordtDepartment of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-5404-5883 Bert van der VegtDepartment of Pathology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0002-2613-1506 Andor W J M GlaudemansDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0001-8081-0641 Adrienne H BrouwersDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0003-2698-1516 Daniela E Oprea-LagerDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Wim J G OyenDepartment of Radiology and Nuclear Medicine, Radboud Medical Center, 6500 HK Nijmegen, The Netherlands.ORCID 0000-0001-8235-7078 Jasper EmmeringDepartment of Radiology and Nuclear Medicine, Erasmus MC, 3000 KP Rotterdam, The Netherlands.ORCID 0000-0002-1453-4308 Anieta M SieuwertsDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.
Agnes JagerDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.
Jaco KraanDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.ORCID 0000-0001-7445-7984 John W M MartensDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.ORCID 0000-0002-3428-3366 Elisabeth G E de VriesDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Stefan SleijferDepartment of Medical Oncology, Erasmus MC Cancer Institute, 3015 GE Rotterdam, The Netherlands.
Carolina P SchröderDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0001-7537-489X IMPACT-MBC Consortium
Funding
Dutch Cancer Society grant IMPACT (RUG 2012-5565)Pink Ribbon project 2014: Optimal circulating tumor cell detection and molecular charac-252 terization of ER and HER2 for treatment prediction
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
18F-FES-PETcirculating tumor cellsendocrine therapyestrogen receptorimmunohistochemistrymetastatic breast cancer
Identifiers
PMID42072822
PMCPMC13114810
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390